COVID-19 has caused unprecedented societal turmoil, triggering a rapid, still ongoing, transformation of healthcare provision on a global level. In this new landscape, it is highly important to acknowledge the challenges this pandemic poses on the care of the particularly vulnerable cancer patients and the subsequent psychosocial impact on them. We have outlined our clinical experience in managing patients with gastrointestinal, hematological, gynaecological, dermatological, neurological, thyroid, lung and paediatric cancers in the COVID-19 era and have reviewed the emerging literature around barriers to care of oncology patients and how this crisis affects them. Moreover, evolving treatment strategies and novel ways of addressing the needs of oncology patients in the new context of the pandemic are discussed. Contents 1. Introduction 2. Oncology care in general 3. Challenges in managing specific types of cancers 4. Conclusions

Aim:To explore and discuss the necessity of integrating the history of medicine within the medical curriculum. Methods: International peer-reviewed academic journals, PubMed and MedLine databases and secondary sources were explored to review historical events that revolutionalized the practice of medicine, surgery, pharmaceuticals and robotics, among others. Results: Numerous case studies have been presented in chronological order, which have made a sustainable impact on clinical practice. The profiles of pioneers and the historical events that led to a chain reaction of advancement in the history of medicine have been discussed, with a view to their impact on future achievements. History should still play an integral role within undergraduate and postgraduate medical education.

No abstract

No abstract